You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

Bulk Pharmaceutical API Sources for ORAPRED ODT


✉ Email this page to a colleague

« Back to Dashboard


Bulk Pharmaceutical API Sources for ORAPRED ODT

Vendor Vendor Homepage Vendor Sku API Url
TCI (Tokyo Chemical Industry) ⤷  Start Trial D3918 ⤷  Start Trial
Amadis Chemical ⤷  Start Trial A805337 ⤷  Start Trial
Finetech Industry Limited ⤷  Start Trial FT-0631728 ⤷  Start Trial
Molport ⤷  Start Trial MolPort-019-991-120 ⤷  Start Trial
AKos Consulting & Solutions ⤷  Start Trial AKOS025310687 ⤷  Start Trial
>Vendor >Vendor Homepage >Vendor Sku >API Url

Bulk Active Pharmaceutical Ingredient (API) Sources for ORAPRED ODT

Last updated: August 5, 2025

Introduction

Orapred ODT (oral disintegrating tablet) is a pharmaceutical formulation containing prednisolone as its primary active pharmaceutical ingredient (API). Prednisolone, a synthetic glucocorticoid, exerts anti-inflammatory and immunosuppressive effects, making it vital in managing conditions such as allergies, autoimmune diseases, and hematological disorders. With increasing demand for orphan and chronic therapies, securing reliable, high-quality API sources is essential for pharmaceutical manufacturers aiming to ensure product consistency, regulatory compliance, and supply chain resilience.

Overview of Prednisolone API

Prednisolone, chemically known as 9α-Fluoro-11β,17α,21-trihydroxypregna-1,4-diene-3,20-dione, is a corticosteroid with a well-established synthesis route and global manufacturing footprint. Its production involves multiple synthetic pathways, often utilizing starting materials and intermediates that influence quality and cost. The API must meet stringent pharmacopeial standards, including purity, potency, and impurity profiles, to ensure the safety and efficacy of formulations like Orapred ODT.

Global API Manufacturers and Key Sources

1. Major International API Suppliers

Numerous pharmaceutical giants and Contract Manufacturing Organizations (CMOs) supply premium-grade prednisolone API globally. These suppliers typically boast extensive Good Manufacturing Practice (GMP) certifications, robust quality management systems, and supply chain infrastructure.

  • Pfizer Inc.
    As the original developer of prednisolone, Pfizer remains a reputable supplier providing high-quality APIs for its formulations. Their global manufacturing facilities adhere to strict GMP standards, and they supply to both branded and generic markets.

  • Sun Pharmaceutical Industries Ltd.
    Recognized as one of India's leading pharmaceutical manufacturers, Sun Pharma supplies prednisolone API to numerous markets. They operate multiple GMP-certified production plants, ensuring consistent quality.

  • Hetero Labs Ltd.
    An Indian pharmaceutical powerhouse, Hetero offers high-grade APIs, including prednisolone, with a focus on cost competitiveness and regulatory compliance.

  • Sandoz (Novartis)
    A global leader in generic medicines, Sandoz supplies prednisolone API through its extensive manufacturing network, emphasizing high purity standards and regulatory approval.

  • TEVA Pharmaceuticals
    As one of the world's largest generic drug manufacturers, TEVA provides prednisolone API meeting international pharmacopeial standards, supporting their broad portfolio of corticosteroid products.

2. Regional API Producers

  • Chinese Manufacturers
    Several Chinese pharmaceutical companies such as Zhejiang Inno Pharmchem Co., Ltd. and Hebei Dongyue Pharmaceutical Co., Ltd. produce prednisolone API. These suppliers often focus on cost-effective production while complying with international GMP standards. However, due diligence regarding regulatory compliance and quality documentation is crucial.

  • European Suppliers
    Companies like Synthesis and Evonik Industries supply high-quality APIs, with stringent adherence to European Pharmacopoeia (EP) standards, suitable for markets with rigorous regulatory requirements.

3. Contract Manufacturing Organizations (CMOs)

  • LGM Pharma and CordenPharma facilitate sourcing of prednisolone API for clients seeking custom synthesis, bulk supply, or contract manufacturing. These organizations often provide comprehensive certification, stability data, and regulatory support.

Criteria for Selecting API Sources

When sourcing prednisolone API for formulations like Orapred ODT, manufacturers should evaluate suppliers based on:

  • Regulatory Certification: GMP compliance, FDA/EMA authorizations, and pharmacopeial adherence.
  • Manufacturing Capacity & Reliability: Consistent supply volume, lead times, and quality control protocols.
  • Quality Documentation: Certificates of Analysis (COA), material safety data sheets, and batch records.
  • Impurity Profile & Purity Level: Meeting pharmacopoeial specifications (e.g., EP, USP, JP) with minimal impurities.
  • Cost & Logistics: Competitive pricing, shipping stability, and customs clearance capabilities.

Supply Chain Considerations

Given geopolitical influences and global supply chain disruptions, diversifying API procurement sources enhances resilience. Engaging multiple suppliers across different regions mitigates risks related to manufacturing delays, regulatory changes, or supply shortages. Strategic partnerships with reputable suppliers that consistently meet quality and regulatory benchmarks are critical for continuous production of Orapred ODT.

Regulatory and Quality Assurance

The API's regulatory landscape is pivotal in supplier selection. Manufacturers should verify regulatory approvals, such as FDA and EMA inspections, and ensure the API suppliers' facilities align with current Good Manufacturing Practices (cGMP). Regular audits and quality verification processes uphold the integrity of the supply chain.

Emerging Trends in API Sourcing

  • Localization of API production
    Countries like India and China dominate prednisolone API manufacture, prompting efforts to establish regional manufacturing hubs to reduce dependency on distant suppliers.

  • Adoption of Quality by Design (QbD)
    Suppliers implementing QbD principles ensure better control of impurity profiles and consistent batch quality.

  • Technology Transfer & Contract Manufacturing
    For formulations like Orapred ODT, engaging CMOs for custom synthesis or supply chain flexibility is increasingly prevalent, aligning with rapid development and manufacturing requirements.

Conclusion

The sourcing of high-quality prednisolone API for Orapred ODT involves evaluating several global and regional suppliers. Leading international manufacturers like Pfizer, Sun Pharma, Hetero, Sandoz, and TEVA stand out due to their compliance with regulatory standards, manufacturing capacity, and quality assurance systems. Regional suppliers from China and Europe also serve as viable options, especially for cost-sensitive markets, provided they meet stringent quality criteria.

Ensuring supply chain resilience requires diversification, rigorous supplier audits, and adherence to regulatory standards. As demand for corticosteroid formulations continues to grow, forging strategic partnerships with reputable API manufacturers remains essential for pharmaceutical companies committed to delivering safe, effective, and consistent therapies.


Key Takeaways

  • Prednisolone API essential for manufacturing Orapred ODT is supplied globally by major players like Pfizer, Sun Pharma, and Sandoz, each with established quality standards.
  • Regional suppliers from China and Europe offer additional options, but due diligence on regulatory compliance is critical.
  • Supplier selection should prioritize GMP certification, high purity profiles, reliable capacity, and regulatory approval status.
  • Diversifying API sources mitigates supply chain risks amid geopolitical and logistical challenges.
  • Engagement with CMOs and adoption of quality management practices support flexible, compliant sourcing strategies.

FAQs

1. What are the primary quality considerations when sourcing prednisolone API?
Quality considerations include purity levels conforming to pharmacopeial standards, impurity profiles, consistent batch-to-batch quality, and compliance with GMP certification and regulatory approvals such as FDA or EMA.

2. How does regional manufacturing impact API sourcing decisions?
Regional manufacturing can reduce lead times and costs but requires thorough validation of regulatory compliance and quality standards, especially for markets with strict pharmacopeial requirements like Europe and North America.

3. Can prednisolone APIs from China meet international regulatory standards?
Yes, many Chinese manufacturers produce GMP-compliant prednisolone API. However, comprehensive validation, documentation, and audits are necessary to ensure suitability for regulated markets.

4. What role do CMOs play in prednisolone API supply chains?
CMOs facilitate contract-based synthesis, supply, and quality assurance, offering flexibility, capacity expansion, and customized formulations aligned with client regulatory and quality requirements.

5. Why is supply chain diversification important for API procurement?
Diversification minimizes risks associated with geopolitical issues, regulatory changes, and manufacturing disruptions, ensuring continuous supply for formulations like Orapred ODT.


Sources:

  1. "Prednisolone API." Pharmacopeial Standards, USP and EP Monographs.
  2. Pfizer Official Website. "Active Pharmaceutical Ingredient Supply."
  3. Sun Pharmaceutical Industries Ltd. Product Catalog.
  4. Hetero Pharma. API Manufacturing Capabilities.
  5. Sandoz Official Communications. API Quality Standards.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.